SYNH - INCリサ―チ・ホ―ルディングス (Syneos Health Inc.) INCリサ―チ・ホ―ルディングス



symbol SYNH
会社名 Syneos Health Inc (INCリサ―チ・ホ―ルディングス)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 シネース・ヘルス(Syneos Health Inc.)(旧名:INC Research Holdings Inc.)はグローバル契約研究機関(CRO)である。同社はバイオ医薬品および医療機器業界のフェーズⅠからフェーズⅣ臨床開発サービスを主とする。同社は2つの事業セグメントを運営する。臨床開発サービス事業は、フルサービスのグローバル調査、並びに臨床モニタリング、調査者採用、患者募集、データ管理、顧客の医薬品開発プロセス、品質保証監査、専門的なコンサルティングサービスを支援するための調査報告書などの付帯サービスを含む一連の臨床開発サービスを提供する。フェーズⅠサービス事業は、フェーズⅠ試験の臨床開発サービスに重点を置く。フェーズⅠ試験には、科学的探索医学、概念実証段階によるヒト初回試験、確立された化合物におけるフェーズⅠ試験のサポートが含まれる。   INCリサ―チ・ホ―ルディングスは米国の開発業務受託機関(CRO)持株会社。バイオ医薬品及び医療デバイス業界の第一・第二臨床開発サ―ビスに重点を置く。中枢神経系、腫瘍学及びその他の複雑な疾患で、分化した治療アライメントや知識を顧客に提供。顧客のバイオ医薬品化合物、研究開発、投資、及び諸経費軽減の開発に注力したサ―ビスを提供。   Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life® visit
本社所在地 3201 Beechleaf Court Suite 600 Raleigh NC 27604-1547 USA
設立年月日 40391
市場名 NASDAQ National Market System
ipoyear 2014年
従業員数 21000人
終値(lastsale) 47.545
時価総額(marketcap) 4892907251.055
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --



   Syneos Health Q3 2021 Earnings Preview  2021/11/02 17:36:35 Seeking Alpha
   Syneos Health, Inc. (NASDAQ:SYNH) Shares Purchased by Squarepoint Ops LLC  2021/10/31 15:22:43 Dakota Financial News
Squarepoint Ops LLC increased its holdings in shares of Syneos Health, Inc. (NASDAQ:SYNH) by 46.1% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 120,468 shares of the companys stock after purchasing an additional 37,990 shares during the quarter. Squarepoint Ops LLC owned 0.12% []
   Virginia Retirement Systems ET AL Buys New Shares in Syneos Health, Inc. (NASDAQ:SYNH)  2021/10/24 10:26:46 Transcript Daily
Virginia Retirement Systems ET AL bought a new position in Syneos Health, Inc. (NASDAQ:SYNH) in the 2nd quarter, according to its most recent disclosure with the SEC. The firm bought 2,400 shares of the companys stock, valued at approximately $215,000. Other large investors also recently bought and sold shares of the company. FMR LLC lifted []
   Healthcare Staffing Market to See Huge Growth by 2026 | Syneos Health, TeamHealth, Jackson Healthcare  2021/10/22 19:42:00 iCrowdNewswire
A Latest intelligence report published by AMA Research with title Healthcare Staffing Market Outlook to 2026. A detailed study accumulated to offer Latest insights about acute features of the Global Healthcare Staffing Market. This report provides a detailed overview of []
   Silvercrest Asset Management Group LLC Has $22.75 Million Stock Holdings in Syneos Health, Inc. (NASDAQ:SYNH)  2021/10/22 16:20:42 Dakota Financial News
Silvercrest Asset Management Group LLC reduced its position in shares of Syneos Health, Inc. (NASDAQ:SYNH) by 1.5% during the second quarter, Holdings Channel reports. The institutional investor owned 254,185 shares of the companys stock after selling 3,763 shares during the period. Silvercrest Asset Management Group LLCs holdings in Syneos Health were worth $22,747,000 as of []
   Syneos Health partners with Ride Health to improve clinical trial recruitment  2021/09/09 13:31:01 Seeking Alpha
   Novan Engages Syneos Health as Commercial Solutions Provider for SB206  2021/09/08 13:00:00 Intrado Digital Media
Company targeting New Drug Application (NDA) for SB206 in Q3 2022, following recent clinically and statistically significant topline efficacy results from a pivotal Phase 3 B-SIMPLE4 trial in patients with molluscum contagiosum
   The Daily Biotech Pulse: MacroGenics'' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA''s FDA Nod  2021/09/08 11:32:07 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc. (NASDAQ: ADIL ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Candel Therapeutics, Inc. (NASDAQ: CADL ) (announced completion of patient enrollment in the pivotal phase 3 study of CAN-2409 in prostate cancer) Cardiol Therapeutics Inc. (NASDAQ: CRDL ) (announced addition to its board) Caribou Biosciences, Inc. (NASDAQ: CRBU ) Catalent, Inc. (NASDAQ: CTLT ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN ) Edwards Lifesciences Corporation (NYSE: EW ) Erasca, Inc. (NASDAQ: ERAS ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Imago BioSciences, Inc. (NASDAQ: IMGO ) INmune Bio, Inc. (NASDAQ: INMB ) Insulet Corporation (NASDAQ: PODD ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Lyell Immunopharma, Inc. (NASDAQ: LYEL ) Medpace Holdings, Inc. (NASDAQ: MEDP ) MiMedx Group, Inc. (NASDAQ: MDXG ) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE ) Nuvalent, Inc. (NASDAQ: NUVL ) PAVmed Inc. (NASDAQ: PAVM ) Protagonist Therapeutics, Inc. (NASDAQ: PTGX ) (reacted to an executive appointment) Psychemedics Corporation (NASDAQ: PMD ) Quest Diagnostics Incorporated (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) Repligen Corporation (NASDAQ: RGEN ) ShockWave Medical, Inc. (NASDAQ: SWAV ) Surrozen, Inc. (NASDAQ: SRZN ) ( reacted to positive analyst action) Syneos Health, Inc. (NASDAQ: SYNH ) Tandem Diabetes Care, Inc. (NASDAQ: TNDM ) (reacted to the news of inclusion of the stock to the S&P MidCap 400 Index) Tango Therapeutics, Inc. (NASDAQ: TNGX ) Verve Therapeutics, Inc. (NASDAQ: VERV ) Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL ) Down In The Dumps No NYSE- or Nasdaq-listed stock hit 52-week lows Tuesday.
   Syneos Health Inc (SYNH) CFO Jason M. Meggs Sold $876,185 of Shares  2021/09/04 00:15:01 GuruFocus
Related Stocks: SYNH ,
   Syneos Health Inc (SYNH): Price Now Near $94.48; Daily Chart Shows An Uptrend on 20 Day Basis  2021/09/03 15:18:24 ETF Daily News
Regarding the trend, note that the strongest trend exists on the 100 day timeframe. The post Syneos Health Inc (SYNH): Price Now Near $94.48; Daily Chart Shows An Uptrend on 20 Day Basis appeared first on ETF Daily News .
   Healthcare Staffing Market: Approach to Gain Momentum by Players - Cross Country Healthcare, Inc., AMN Healthcare, Syneos Health, Inc., CHG Management, Inc., Maxim Healthcare Services, Inc.  2021/08/31 13:29:56 OpenPR
According to Decisive Markets Insights'' New Report "Healthcare Staffing Market ", it analyses the competitive landscape and its future growth prospects. For the analysis period of 2020 - 2027, the report of the Market includes a detailed study of some
   The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical  2021/08/31 12:05:06 Benzinga
Here''s a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN ) Alkermes plc (NASDAQ: ALKS ) Axonics, Inc. (NASDAQ: AXNX ) Bio-Techne Corporation (NASDAQ: TECH ) BioLife Solutions, Inc. (NASDAQ: BLFS ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE ) Clearside Biomedical, Inc. (NASDAQ: CLSD ) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX ) Cytokinetics, Incorporated (NASDAQ: CYTK ) Dermata Therapeutics, Inc. (NASDAQ: DRMA ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Eliem Therapeutics, Inc. (NASDAQ: ELYM ) (IPOed Aug. 10) Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA ) IVERIC bio, Inc. (NASDAQ: ISEE ) Kezar Life Sciences, Inc. (NASDAQ: KZR ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) MiMedx Group, Inc. (NASDAQ: MDXG ) PDS Biotechnology Corporation (NASDAQ: PDSB ) Pieris Pharmaceuticals, Inc.
   Syneos Health to Present at the 2021 Baird Global Healthcare Conference  2021/08/30 13:00:00 Intrado Digital Media
MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present at the 2021 Baird Global Healthcare Conference on September 15, 2021, at 1:25 p.m. ET.
   Clinical Trial Services Market Significantly Stepping towards the Success Till 2027| Labcorp, IQVIA, Syneos Health, Parexel  2021/08/16 13:47:39 OpenPR
Support for Clinical Trials Over the previous few years, the market has grown at a faster rate, with significant growth rates. The increasing interest of pharmaceutical corporations in producing and sponsoring clinical trials and drug development is a major driver
   Earnings: Bandwidth, Syneos Health beat Street; Asensus Surgical reports loss | WRAL TechWire  2021/08/09 17:55:08 WRAL TechWire
Earnings season continues with Triangle area firms reporting more financial updates, including Bandwidth, Syneos Health and Asensus Surgical (formerly known as

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 INCリサ―チ・ホ―ルディングス SYNH Syneos Health Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)